Azora Therapeutics, Inc. (DE) (AZR) stock forecast and price target
Price $4.09 · data as of November 13, 2026
12-month price target
Average target$10.67
Upside / downside+160.8%
Analysts3
ConsensusStrong buy
Low $6.00Average $10.67High $14.00
Gold marker: average target · white marker: today’s price ($4.09)
Analyst ratings
Strong buy 1Buy 3Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-4.94 | — | $0 |
| Next fiscal year ends December 31, 2027 | $-0.49 | +90.1% | $0 |
| Next quarter ends December 31, 2026 | $-0.13 | — | $0 |
Consensus of the analysts covering Azora Therapeutics, Inc. (DE), updated daily.
Frequently asked questions
What is the Azora Therapeutics, Inc. (DE) stock price target?
The average 12-month target from 3 analysts is $10.67, 160.8% above the current price of $4.09 Targets range from $6.00 to $14.00.
Is Azora Therapeutics, Inc. (DE) a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 3 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Azora Therapeutics, Inc. (DE) expected to earn?
Analysts expect EPS of $-4.94 for the fiscal year ending December 31, 2026 and $-0.49 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.